K-ras mutations correlate with atypical cytology and elevated CEA levels in pancreatic cystic neoplasms

Digestive Diseases and Sciences

Volumn 56, Issue 7, 2011, Pages 2197-2201

  Mertz, Howard ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Atypia; Carcinoembryonic antigen; Endoscopic ultrasound; Fine needle aspiration; K ras mutation; Pancreatic cystic neoplasm

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; K RAS PROTEIN;

ADOLESCENT; ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER SURGERY; CYTOLOGY; DNA DETERMINATION; FEMALE; GENE MUTATION; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CYST; PANCREAS DUCT; PRIORITY JOURNAL; WILD TYPE;

ADENOCARCINOMA; AGED; BIOPSY, FINE-NEEDLE; CARCINOEMBRYONIC ANTIGEN; CYST FLUID; GENES, RAS; HUMANS; MIDDLE AGED; MUTATION; PANCREATIC CYST; PANCREATIC NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 79959702215     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-010-1556-z     Document Type: Article

References (22)

1. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
2. Rodriguez J, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007;133:72-79. (Pubitemid 47031144)
3. Levy P, Jouannaud V, O'Toole D, et al. Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol. 2006;4:460.
4. Hruban R, Takaori K, Klimstra D, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977-987. (Pubitemid 38971421)
5. Gompel C. Atlas of diagnostic cytology. New York: Wiley; 1978: 74-75.
6. Brugge W, Lewandrowski K, Lee-Lewandrowski E, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004;126:1330-1336. (Pubitemid 38552797)
7. Van der Waij L, Dullemen H, Porte R, et al. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc. 2005;62:383.
8. Pais S, Attasaranya S, Leblanc J, et al. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology. Clin Gastroenterol Hepatol. 2007;5:489-495. (Pubitemid 46575363)
9. Pinto M, Meriano F. Diagnosis of cystic pancreatic lesions by cytologic examination and carcinoembryonic antigen and amylase assays of cyst contents. Acta Cytol. 1991;35:456-463.
10. Khalid A, McGrath K, Zahid M, et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol. 2005;3:967-973. (Pubitemid 41415743)
11. Linder J, Geenen J, Catalano M. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience. Gastrointest Endosc. 2006;64:697.
12. Froussard J, Amouyal P, Amouyal G, et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol. 2003; 98:1516-1524. (Pubitemid 36875343)
13. Khalid A, Brugge W. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol. 2007;102:2339-2349. (Pubitemid 47493853)
14. Brugge W. Should all pancreatic cystic lesions be resected? Cyst-fluid analysis in the differential diagnosis of pancreatic cystic lesions: a meta-analysis. Gastrointest Endosc. 2005;62:390-391. (Pubitemid 41187941)
15. Vogelstein B, Fearon E, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. New England J Med. 1988;319:555.
16. Z'graggen K, Rivera J, Compton C, et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in the intraductal papillary mucinous tumors of the pancreas. Annals Surg. 1997;226:491-500.
17. Wada K. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J Hepatobiliary Pancreat Surg. 2002;9:76-85.
18. Soldini D, Gugger M, Burckhardt E, et al. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts. J Pathol. 2003;199:453-461. (Pubitemid 36411222)
19. Khalid A, Zahid M, Finkelstein S, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc. 2009;69:1098-1102.
20. Schoedel K, Finkelstein S, Ohori N. K-ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas. Diagn Cytopathol. 2006;34: 605-608. (Pubitemid 44298560)
21. Ji B, Tsou L, Wand H, et al. Ras activity levels control the development of pancreatic diseases. Gastroenterology. 2009;137: 1072-1082.
22. Kopnin PB, Agapova LS, Kopnin BP, et al. Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability. Cancer Res. 2007;67:4671-4678. (Pubitemid 46910172)